Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17087947 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Lipid Efficacy/Tolerability Study (0524A-020)
Conditions: Primary Hypercholesterolaemia;   Mixed Hyperlipidaemia
Interventions: Drug: niacin (+) laropiprant;   Drug: ER-niacin
2 Completed A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)
Condition: Colorectal Adenoma
Interventions: Drug: MK0966; Rofecoxib / Duration of Treatment: 156 weeks;   Drug: Placebo/ Duration of Treatment: 156 weeks

Indicates status has not been verified in more than two years